# Efficacy of Ketorolac 0.4% in Prostaglandin Suppression

> **NCT00791323** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 9 (actual)

## Conditions studied

- Inflammation

## Interventions

- **DRUG:** Ketorolac 0.4%
- **DRUG:** Lubricating Eye Drop

## Key facts

- **NCT ID:** NCT00791323
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2011-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00791323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00791323, "Efficacy of Ketorolac 0.4% in Prostaglandin Suppression". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00791323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*